Financhill
Buy
58

CRH Quote, Financials, Valuation and Earnings

Last price:
$125.97
Seasonality move :
4.52%
Day range:
$121.71 - $126.30
52-week range:
$76.75 - $131.55
Dividend yield:
1.17%
P/E ratio:
25.07x
P/S ratio:
2.32x
P/B ratio:
3.61x
Volume:
4.2M
Avg. volume:
4.7M
1-year change:
18.28%
Market cap:
$84.2B
Revenue:
$35.6B
EPS (TTM):
$5.03

Analysts' Opinion

  • Consensus Rating
    CRH Plc has received a consensus rating of Buy. The company's average rating is a Buy based on 15 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $140.46, CRH Plc has an estimated upside of 11.51% from its current price of $125.97.
  • Price Target Downside
    According to analysts, the lowest downside price target is $96.00 representing 100% downside risk from its current price of $125.97.

Fair Value

  • According to the consensus of 18 analysts, CRH Plc has 11.51% upside to fair value with a price target of $140.46 per share.

CRH vs. S&P 500

  • Over the past 5 trading days, CRH Plc has overperformed the S&P 500 by 0.53% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • CRH Plc does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • CRH Plc has grown year-over-year revenues for 5 quarters straight. In the most recent quarter CRH Plc reported revenues of $11.1B.

Earnings Growth

  • CRH Plc has grown year-over-year earnings for 2 quarters straight. In the most recent quarter CRH Plc reported earnings per share of $2.21.
Enterprise value:
101.8B
EV / Invested capital:
--
Price / LTM sales:
2.32x
EV / EBIT:
19.74x
EV / Revenue:
2.76x
PEG ratio (5yr expected):
51.17x
EV / Free cash flow:
38.46x
Price / Operating cash flow:
32.27x
Enterprise value / EBITDA:
14.00x
Gross Profit (TTM):
$13.3B
Return On Assets:
6.5%
Net Income Margin (TTM):
9.38%
Return On Equity:
14.84%
Return On Invested Capital:
8.55%
Operating Margin:
17.95%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $33.9B $35.4B $36.9B $10.5B $11.1B
Gross Profit $9B $12.5B $13.3B $4.1B $4.3B
Operating Income $3.9B $4.8B $5.2B $1.9B $2B
EBITDA $5.3B $6.5B $7.3B $2.4B $2.6B
Diluted EPS $3.37 $5.00 $5.03 $1.97 $2.21
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets -- -- $16.3B $14.8B $16.9B
Total Assets -- -- $47.6B $51.2B $58.5B
Current Liabilities -- -- $9.2B $10.7B $11.6B
Total Liabilities -- -- $25B $28.1B $33.9B
Total Equity -- -- $22.6B $23.2B $24.6B
Total Debt -- -- $12.6B $15.2B $20.4B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -- $4.7B $5.5B $1.5B $2.1B
Cash From Investing -- -$5.1B -$6.7B -$1.9B -$3.1B
Cash From Financing -- -$2.4B $2.4B -$643M $2.4B
Free Cash Flow -- $2.4B $2.6B $993.4M $1.5B
CRH
Sector
Market Cap
$84.2B
$24.4M
Price % of 52-Week High
95.76%
72.52%
Dividend Yield
1.17%
0%
Shareholder Yield
1.24%
-3.03%
1-Year Price Total Return
18.28%
20%
Beta (5-Year)
1.340
0.594
Dividend yield:
1.17%
Annualized payout:
$1.40
Payout ratio:
16.71%
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $125.56
200-day SMA
Buy
Level $110.25
Bollinger Bands (100)
Buy
Level 115.07 - 126.03
Chaikin Money Flow
Buy
Level 353.8M
20-day SMA
Buy
Level $123.91
Relative Strength Index (RSI14)
Buy
Level 52.42
ADX Line
Buy
Level 15.84
Williams %R
Neutral
Level -42.1281
50-day SMA
Buy
Level $125.01
MACD (12, 26)
Buy
Level 0.50
25-day Aroon Oscillator
Sell
Level -28
On Balance Volume
Neutral
Level 90.9M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (3.1326)
Buy
CA Score (Annual)
Level (-0.036)
Buy
Beneish M-Score (Annual)
Level (-2.5415)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-1.3593)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (9)

Revenue Forecast

Earnings per Share Forecast

Company Profile

CRH Plc manufactures and distributes building materials and products for the construction industry. It operates business through the following segments: Americas Materials Solutions, Americas Building Solutions, Europe Materials Solutions, and Europe Building Solutions. The Americas Materials Solutions segment provides solutions for the construction and maintenance of public infrastructure and commercial and residential buildings in North America. The Americas Building Solutions segment manufactures, supplies and delivers solutions for the built environment in communities across North America. The Europe Materials Solutions segment provides solutions for the construction of public infrastructure and commercial and residential buildings to customers in construction markets in Europe. The Europe Building Solutions segment combines materials, products and services to produce a wide range of architectural and infrastructural solutions for use in the building and renovation of critical utility infrastructure, commercial and residential buildings, and outdoor living spaces. CRH was founded on June 20, 1949 and is headquartered in New York, NY.

Stock Forecast FAQ

In the current month, CRH has received 15 Buy ratings 3 Hold ratings, and 0 Sell ratings. The CRH average analyst price target in the past 3 months is $140.46.

  • Where Will CRH Plc Stock Be In 1 Year?

    According to analysts, the consensus estimate is that CRH Plc share price will rise to $140.46 per share over the next 12 months.

  • What Do Analysts Say About CRH Plc?

    Analysts are divided on their view about CRH Plc share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that CRH Plc is a Sell and believe this share price will drop from its current level to $96.00.

  • What Is CRH Plc's Price Target?

    The price target for CRH Plc over the next 1-year time period is forecast to be $140.46 according to 18 Wall Street analysts, 15 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.

  • Is CRH A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for CRH Plc is a Buy. 15 of 18 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of CRH?

    You can purchase shares of CRH Plc via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase CRH Plc shares.

  • What Is The CRH Plc Share Price Today?

    CRH Plc was last trading at $125.97 per share. This represents the most recent stock quote for CRH Plc. Yesterday, CRH Plc closed at $125.97 per share.

  • How To Buy CRH Plc Stock Online?

    In order to purchase CRH Plc stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?
Will UnitedHealth Stock Recover?

Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…

Is Lumentum The Best Laser Stock to Buy?
Is Lumentum The Best Laser Stock to Buy?

Though certainly less well-known than the huge tech businesses that…

Is Planet Fitness Stock Undervalued?
Is Planet Fitness Stock Undervalued?

Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 34x

Sell
44
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Buy
77
CPS alert for Feb 14

Cooper-Standard Holdings, Inc. [CPS] is up 32.06% over the past day.

Buy
58
TPH alert for Feb 14

Tri Pointe Homes, Inc. [TPH] is up 26.83% over the past day.

Sell
20
IRON alert for Feb 14

Disc Medicine, Inc. [IRON] is down 21.88% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock